Conquering the beyond Rule of Five Space with an Optimized High-Throughput Caco-2 Assay to Close Gaps in Absorption Prediction
Current drug development tends towards complex chemical molecules, referred to as "beyond rule of five" (bRo5) compounds, which often exhibit challenging physicochemical properties. Measuring Caco-2 permeability of those compounds is difficult due to technical limitations, including poor r...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2024-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_a94c5963141f476788baf6d1cae2be35 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Patricia Muschong |e author |
| 700 | 1 | 0 | |a Khader Awwad |e author |
| 700 | 1 | 0 | |a Edward Price |e author |
| 700 | 1 | 0 | |a Mario Mezler |e author |
| 700 | 1 | 0 | |a Manuel Weinheimer |e author |
| 245 | 0 | 0 | |a Conquering the beyond Rule of Five Space with an Optimized High-Throughput Caco-2 Assay to Close Gaps in Absorption Prediction |
| 260 | |b MDPI AG, |c 2024-06-01T00:00:00Z. | ||
| 500 | |a 10.3390/pharmaceutics16070846 | ||
| 500 | |a 1999-4923 | ||
| 520 | |a Current drug development tends towards complex chemical molecules, referred to as "beyond rule of five" (bRo5) compounds, which often exhibit challenging physicochemical properties. Measuring Caco-2 permeability of those compounds is difficult due to technical limitations, including poor recovery and detection sensitivity. We implemented a novel assay, with optimized incubation and analytics, to measure permeability close to equilibrium. In this setup an appropriate characterization of permeability for bRo5 compounds is achievable. This equilibrated Caco-2 assay was verified with respect to data validity, compound recovery, and in vitro to in vivo correlation for human absorption. Compared to a standard assay, it demonstrated comparable performance in predicting the human fraction absorbed (f<sub>a</sub>) for reference compounds. The equilibrated assay also successfully characterized the permeability of more than 90% of the compounds analyzed, the majority of which were bRo5 (68%). These compounds could not be measured using the standard assay. Permeability and efflux ratio (ER) were highly predictive for in vivo absorption for a large set of internal bRo5 compounds. Reference cut-offs enabled the correct classification of high, moderate, and low absorption. This optimized equilibrated Caco-2 assay closes the gap for a high-throughput cellular permeability method in the bRo5 chemical space. | ||
| 546 | |a EN | ||
| 690 | |a Caco-2 | ||
| 690 | |a beyond rule of five (bRo5) | ||
| 690 | |a proteolysis targeting chimera (PROTAC) | ||
| 690 | |a absorption | ||
| 690 | |a permeability | ||
| 690 | |a in vitro assay | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pharmaceutics, Vol 16, Iss 7, p 846 (2024) | |
| 787 | 0 | |n https://www.mdpi.com/1999-4923/16/7/846 | |
| 787 | 0 | |n https://doaj.org/toc/1999-4923 | |
| 856 | 4 | 1 | |u https://doaj.org/article/a94c5963141f476788baf6d1cae2be35 |z Connect to this object online. |